229 related articles for article (PubMed ID: 24449338)
1. Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
Young KA; Terrell DR; Guthridge JM; Kamen DL; Gilkeson GS; Karp DR; Ishimori ML; Weisman MH; Holers VM; Harley JB; Norris JM; James JA
Lupus; 2014 Apr; 23(4):360-9. PubMed ID: 24449338
[TBL] [Abstract][Full Text] [Related]
2. Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members.
Bruner BF; Guthridge JM; Lu R; Vidal G; Kelly JA; Robertson JM; Kamen DL; Gilkeson GS; Neas BR; Reichlin M; Scofield RH; Harley JB; James JA
Arthritis Rheum; 2012 Nov; 64(11):3677-86. PubMed ID: 23112091
[TBL] [Abstract][Full Text] [Related]
3. First-degree relatives of patients with systemic lupus erythematosus: Autoreactivity but not autoimmunity?
Penev B; Vasilev G; Todorova EI; Tumangelova-Yuzeir K; Kurteva E; Monov S; Kyurkchiev D
Int J Rheum Dis; 2023 May; 26(5):907-916. PubMed ID: 36942901
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach.
Laustrup H; Heegaard NH; Voss A; Green A; Lillevang ST; Junker P
Lupus; 2004; 13(10):792-9. PubMed ID: 15540512
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up.
Langkilde H; Voss A; Heegaard N; Laustrup H
Lupus; 2017 Jun; 26(7):723-728. PubMed ID: 27831535
[TBL] [Abstract][Full Text] [Related]
6. Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives.
Navarra SV; Ishimori MI; Uy EA; Hamijoyo L; Sama J; James JA; Holers VM; Weisman MH
Lupus; 2011 Apr; 20(5):537-43. PubMed ID: 21183559
[TBL] [Abstract][Full Text] [Related]
7. A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.
Ogunrinde E; Zhou Z; Luo Z; Alekseyenko A; Li QZ; Macedo D; Kamen DL; Oates JC; Gilkeson GS; Jiang W
Arthritis Rheumatol; 2019 Nov; 71(11):1858-1868. PubMed ID: 31106972
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Vanderlinden LA; Bemis EA; Seifert J; Guthridge JM; Young KA; Demoruelle MK; Feser M; DeJager W; Macwana S; Mikuls TR; O'Dell JR; Weisman MH; Buckner J; Keating RM; Gaffney PM; Kelly JA; Langefeld CD; Deane KD; James JA; Holers VM; Norris JM
Front Immunol; 2022; 13():881332. PubMed ID: 35720397
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus.
Wandstrat AE; Carr-Johnson F; Branch V; Gray H; Fairhurst AM; Reimold A; Karp D; Wakeland EK; Olsen NJ
J Autoimmun; 2006 Nov; 27(3):153-60. PubMed ID: 17052888
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
[TBL] [Abstract][Full Text] [Related]
11. Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.
James JA; Chen H; Young KA; Bemis EA; Seifert J; Bourn RL; Deane KD; Demoruelle MK; Feser M; O'Dell JR; Weisman MH; Keating RM; Gaffney PM; Kelly JA; Langefeld CD; Harley JB; Robinson W; Hafler DA; O'Connor KC; Buckner J; Guthridge JM; Norris JM; Holers VM
EBioMedicine; 2019 Apr; 42():76-85. PubMed ID: 30952617
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal anti-nuclear antibody (ANA) seroconversion in systemic lupus erythematosus: a prospective study of Swedish cases with recent-onset disease.
Frodlund M; Wetterö J; Dahle C; Dahlström Ö; Skogh T; Rönnelid J; Sjöwall C
Clin Exp Immunol; 2020 Mar; 199(3):245-254. PubMed ID: 31778219
[TBL] [Abstract][Full Text] [Related]
13. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
[TBL] [Abstract][Full Text] [Related]
14. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
Chauhan SK; Rai R; Singh VV; Rai M; Rai G
Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
[TBL] [Abstract][Full Text] [Related]
15. Genetic contributions to the autoantibody profile in a rabbit model of Systemic Lupus Erythematosus (SLE).
Puliyath N; Ray S; Milton J; Mage RG
Vet Immunol Immunopathol; 2008 Oct; 125(3-4):251-67. PubMed ID: 18602165
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls.
Aberle T; Bourn RL; Munroe ME; Chen H; Roberts VC; Guthridge JM; Bean K; Robertson JM; Sivils KL; Rasmussen A; Liles M; Merrill JT; Harley JB; Olsen NJ; Karp DR; James JA
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1780-1788. PubMed ID: 28118528
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for ANA positivity in healthy persons.
Li QZ; Karp DR; Quan J; Branch VK; Zhou J; Lian Y; Chong BF; Wakeland EK; Olsen NJ
Arthritis Res Ther; 2011 Mar; 13(2):R38. PubMed ID: 21366908
[TBL] [Abstract][Full Text] [Related]
18. Comparison of chemiluminescence microparticle immunoassay, indirect immunofluorescence assay, linear immunoassay and multiple microbead immunoassay detecting autoantibodies in systemic lupus erythematosus.
Wei Q; Jiang Y; Xiao M; Zhang X; Qi J; Xie J; Wu J; Wu Z; Gu J
Scand J Immunol; 2020 Mar; 91(3):e12849. PubMed ID: 31899559
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
20. Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.
Munroe ME; Young KA; Guthridge JM; Kamen DL; Gilkeson GS; Weisman MH; Ishimori ML; Wallace DJ; Karp DR; Harley JB; Norris JM; James JA
Front Immunol; 2022; 13():866181. PubMed ID: 35720322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
